WILMINGTON -
A live webcast of the presentations may be accessed by visiting the Events and Presentations section of the
About
Forward-Looking Statements
This press release includes 'forward-looking statements' within the meaning of, and made pursuant to the safe harbor provisions of, the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact, including statements regarding the Company's strategy, future operations, projected prospects, plans and objectives of management, future strategic opportunities, the effect of recent management and board leadership changes, the timing and occurrence of commercial launches, potential indications, research and development plans, indications in development, and the assumptions underlying or relating to such statements, are 'forward-looking statements.' In some cases, these statements can be identified by forward-looking words such as 'expect,' 'plan,' 'anticipate,' 'potential,' 'estimate,' 'can,' 'will,' 'continue,' 'believe,' the negative or plural of these words, and other similar expressions. These forward-looking statements are predictions based on the Company's current expectations and the Company's projections about future events and various assumptions. There can be no assurance that the Company will realize its expectations or that the Company's beliefs will prove correct. There are a number of important factors that could cause the Company's actual results to differ materially from those indicated by such forward-looking statements, including, but not limited to: the timing of regulatory filings and action; the ability of Endo to achieve its objectives for XIAFLEX and Qwo; the market for XIAFLEX in, and timing, initiation, and outcome of clinical trials for, additional indications, which will determine the amount of milestone, royalty, mark-up on cost of goods sold, license, and sublicense income that the Company may receive; the potential of XIAFLEX to be used in additional indications; Endo modifying its objectives or allocating resources other than to XIAFLEX and Qwo; the impacts of the novel coronavirus (COVID-19) global pandemic and other risk factors identified in the Company's Annual Report on Form 10-K for the year ended
Contact:
Tel: 302-842-8450
(C) 2020 Electronic News Publishing, source